Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis (Record no. 8911)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02796 a2200361 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1040300227 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250328151431.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250324022025xx 118 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781040300220 |
| Qualifying information | EA |
| 037 ## - SOURCE OF ACQUISITION | |
| Source of stock number/acquisition | Taylor & Francis |
| Terms of availability | GBP 49.99 |
| Form of issue | BB |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | 01 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PSD |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MJCJ |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MJCM |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBNS |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PSD |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MJCJ |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MJCM |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBNS |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | SCI045000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED044000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED078000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED022090 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | 616.9364 |
| Source | bisac |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Veer Singh |
| 245 10 - TITLE STATEMENT | |
| Title | Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis |
| Remainder of title | Pathogenesis, Treatment and Disease Control |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | CRC Press |
| Date of publication, distribution, etc. | 20250403 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 240 p |
| 520 ## - SUMMARY, ETC. | |
| Expansion of summary note | This reference book explores various aspects of visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL), including their pathophysiology, treatment options, and disease control strategies. The initial chapter provides an overview of VL, its global impact, and pathogenesis. It also examines the development of PKDL from VL, outlining the transition from the acute form of the disease to the chronic dermal condition. The book further explores the symptoms and diagnosis of both VL and PKDL. Furthermore, the book delves into the immunopathogenesis of both VL and PKDL, shedding light on the complex interactions between the parasite and the host immune system. It reviews the impact of environmental factors, particularly the contamination of arsenic and antimony in drinking water, on the progression of the disease. Lastly, the book discusses preventive measures for PKDL and highlights the major challenges in effectively implementing these strategies. This book serves as a useful resource for researchers, healthcare professionals, and policymakers seeking to deepen their understanding of these diseases and develop effective strategies for their prevention and control. Key features Provides in-depth coverage of VL and PKDL, including pathogenesis, treatment, and disease control strategies Elucidates the symptoms and diagnostic methods for VL and PKDL Offers insights into the complex immunopathogenesis of VL and PKDL, exploring the interactions between parasites and host immune system Examines treatment options for both VL and PKDL, including current therapeutic approaches and emerging strategies Reviews the impact of environmental factors, such as arsenic and antimony contamination, on the disease progression Discusses preventive measures and challenges in implementing effective strategies for PKDL prevention and control |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ashish Kumar |
| Relationship | B01 |
No items available.